SSTR2 and synovial sarcoma: Both SSTR2 and SSTR5 mediate the antiproliferative effects of SS by tyrosine phosphatase activation and ERK1/2 phosphorylation inhibition, respectively, whereas only SSTR2 and SST3 subtypes mediate apoptotic effects (9–12).